TheraRadar
← Back
Data updated: Mar 29, 2026

TARO

NeurologyDermatologyCardiovascular
Generics

TARO is a generic drug manufacturer focused on Neurology, Dermatology, Cardiovascular.

1977
Since
85
Drugs
-
Trials
897
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 33%
7 drugs
Dermatology 19%
4 drugs
Cardiovascular 19%
4 drugs
Oncology 14%
3 drugs
Gastroenterology 14%
3 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...